Intramuscular and 3mg Nasal Naloxone

The Wisconsin Intramuscular and 3mg Nasal Naloxone state-wide contract provides a comprehensive procurement vehicle for critical overdose reversal medications. The vehicle covers multiple pharmaceutical categories including sympathomimetic drugs, adrenergic blocking agents, and combination muscle relaxants, with a specific focus on naloxone formulations. These medications are intended for emergency medical services, first responders, healthcare facilities, and public health departments to combat opioid overdose situations effectively.

The contract is administered by the Wisconsin Department of Health Services and is scheduled to remain active through July 15, 2025. While specific prime contractors are not detailed in the provided information, the contract leverages UNSPSC and NIGP codes spanning various pharmaceutical classifications to ensure broad medication accessibility. The vehicle is statewide in geographic coverage and appears to be structured as a multi-award contract designed to provide flexible purchasing options for critical medical interventions across Wisconsin's public health ecosystem.